JUNS logo

Jupiter Neurosciences, Inc. (JUNS)

Profile

Full Name

Jupiter Neurosciences, Inc.

Ticker

NASDAQ: JUNS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 18, 2022

Indexes

Not included

Website

http://jupiterneurosciences.com

Employees

4

Key Details

Price

$2.29(+19.90%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.08(+55.56% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.29
    JUNS price is $2.29

    30-Day Relative Volume

    2.09
    JUNS 30-day relative volume is 2.09

    Price Performance

    Price Most recent change

    +19.9%
    JUNS price was up +19.9% on Jul 11, 2025

    Price YTD change

    -78.6%
    JUNS price is down -78.6% since January 1st

    Price 1-year change

    -
    JUNS price 1-year change is unknown

    Price 3-year change

    -
    JUNS price 3-year change is unknown

    Price Range

    Price All-time high

    $19.51
    JUNS price is currently -88.26% below its historical high of $19.51

    Price 3-year low

    $0.51
    JUNS price is currently +349.02% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $75.81M
    JUNS market capitalization is $75.81 million

    Market cap 3-year change

    -
    JUNS market capitalization 3-year change is unknown

    Market cap All-time high

    $505.31M
    JUNS market capitalization is currently -85.00% below its historical high of $505.31 million

    Market cap sector rank

    40.25%
    JUNS market capitalization is higher than 40.25% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.01%
    JUNS shares outstanding is up +0.01% year-on-year

    Shares Outstanding 3-Year Change

    +278.84%
    JUNS shares outstanding is up +278.84% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -0.06
    JUNS beta is -0.06

    200-day SMA

    $2.61
    JUNS price is currently -12.14% below its 200-day simple moving average

    50-day SMA

    $0.95
    JUNS price is currently +140.42% above its 50-day simple moving average

    RSI

    74.38
    JUNS 14-day relative strength index is 74.38

    Volume

    2.09
    JUNS 30-day relative volume is 2.09

    ATR

    $0.39
    JUNS average true range is $0.39

    10-day Historical Volatility

    238.11%
    JUNS 10-day historical volatility is 238.11%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    JUNS annual revenue value is unknown

    Revenue Analysts estimate

    $175.00K
    JUNS annual revenue is currently equal to the consensus analysts' forecast

    Revenue 1-year change

    -
    JUNS annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    JUNS annual revenue is unknown

    EPS

    EPS

    -$0.08
    JUNS annual earnings per share is -$0.08

    EPS Analysts estimate

    -$0.25
    JUNS annual earnings per share is currently -68.00% lower than the consensus analysts' forecast

    EPS 1-year change

    +55.56%
    JUNS annual earnings per share is up +55.56% year-on-year

    EPS Sector rank

    79.78%
    JUNS annual earnings per share is higher than 79.78% of companies in Healthcare sector

    Profit

    Gross profit

    -
    JUNS annual gross profit value is unknown

    Gross margin

    -
    JUNS annual gross profit margin value is unknown

    Operating profit

    -$3.09M
    JUNS annual operating income is -$3.09 million

    Operating margin

    -
    JUNS annual operating profit margin value is unknown

    Net income

    -$2.44M
    JUNS annual net profit is -$2.44 million

    Net margin

    -
    JUNS annual net profit margin value is unknown

    Expenses

    Total expenses

    $3.09M
    JUNS annual total expenses is $3.09 million

    Operating expenses

    $3.09M
    JUNS annual total operating expenses is $3.09 million

    Cost of goods sold

    -
    JUNS annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $2.60M
    JUNS annual SGA is $2.60 million

    Depreciation and amortization

    -
    JUNS annual depreciation & amortization value is unknown

    Interest expense

    $248.40K
    JUNS annual interest expense is $248.40 thousand

    Income tax

    -
    JUNS annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$2.19M
    JUNS annual earnings before interest & taxes is -$2.19 million

    EBITDA

    -$2.19M
    JUNS annual EBITDA is -$2.19 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $6.20M
    JUNS annual total assets is $6.20 million

    Non current assets

    $1.55M
    JUNS annual long term assets is $1.55 million

    Current assets

    $4.65M
    JUNS annual total current assets is $4.65 million

    Cash and cash equivalents

    $3.77M
    JUNS annual cash & cash equivalents is $3.77 million

    Accounts receivable

    -
    JUNS annual accounts receivable value is unknown

    Inventory

    -
    JUNS annual inventory value is unknown

    Liabilities

    Total liabilities

    $2.03M
    JUNS annual total liabilities is $2.03 million

    Long term liabilities

    $21.20K
    JUNS annual total long term liabilities is $21.20 thousand

    Current liabilities

    $2.01M
    JUNS annual total current liabilities is $2.01 million

    Accounts payable

    $278.70K
    JUNS annual accounts payable is $278.70 thousand

    Debt

    Total debt

    $217.70K
    JUNS annual total debt is $217.70 thousand

    Total debt 1-year change

    -90.32%
    JUNS annual total debt is down -90.32% year-on-year

    Long term debt

    $21.20K
    JUNS annual long term debt is $21.20 thousand

    Short term debt

    $196.50K
    JUNS annual short term debt is $196.50 thousand

    Equity & Capital

    Shareholders equity

    $4.17M
    JUNS annual stockholders equity is $4.17 million

    Book value

    $4.17M
    JUNS annual book value is $4.17 million

    Retained earnings

    -$26.02M
    JUNS annual retained earnings is -$26.02 million

    Working capital

    $2.64M
    JUNS annual working capital is $2.64 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$3.91M
    JUNS annual cash flow from operations is -$3.91 million

    Cash from operations 1-year change

    -713.1%
    JUNS annual cash flow from operations is down -713.1% year-on-year

    Cash from investing

    -
    JUNS annual cash flow from investing activities value is unknown

    Cash from investing 1-year change

    -
    JUNS annual cash flow from investing activities 1-year change is unknown

    Cash from financing

    $7.65M
    JUNS annual cash flow from financing activities is $7.65 million

    Cash from financing 1-year change

    +1619.55%
    JUNS annual cash flow from financing activities is up +1619.55% year-on-year

    CAPEX

    CAPEX

    -
    JUNS annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    JUNS annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$3.91M
    JUNS annual free cash flow is -$3.91 million

    Free cash flow 1-year change

    -713.1%
    JUNS annual free cash flow is down -713.1% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    JUNS annual gross profit margin value is unknown

    Operating margin

    -
    JUNS annual operating profit margin value is unknown

    Net margin

    -
    JUNS annual net profit margin value is unknown

    ROA & ROE

    ROA

    -39.33%
    JUNS annual return on assets is -39.33%

    ROE

    -58.48%
    JUNS annual return on equity is -58.48%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    JUNS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    JUNS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    24.74
    JUNS price to book ratio is 24.74

    PB ratio Sector rank

    96.61%
    JUNS price to book ratio is higher than 96.61% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    JUNS price to sales ratio value is unknown

    PS ratio Sector rank

    -
    JUNS price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $73.31M
    JUNS enterprise value is $73.31 million

    Enterprise value Sector rank

    41.08%
    JUNS enterprise value is higher than 41.08% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -23.35
    JUNS EV/EBITDA is -23.35

    EV/EBITDA Sector rank

    6.86%
    JUNS EV/EBITDA is higher than 6.86% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.31
    JUNS annual current ratio is 2.31

    Quick ratio

    -
    JUNS annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.05
    JUNS annual debt to equity ratio is 0.05

    Interest coverage ratio

    -8.82
    JUNS annual interest coverage ratio is -8.82

    Risk & Stability

    Piotroski F-Score

    -
    JUNS piotroski f-score value is unknown

    Altman Z-Score

    -
    JUNS altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    No data about analysts updates

    Institutional Ownership

    Screeners with JUNS included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Jupiter Neurosciences, Inc.?
    • Does Jupiter Neurosciences, Inc. pay dividends?
    • What sector is Jupiter Neurosciences, Inc. in?
    • What industry is Jupiter Neurosciences, Inc. in?
    • What country is Jupiter Neurosciences, Inc. based in?
    • When did Jupiter Neurosciences, Inc. go public?
    • Is Jupiter Neurosciences, Inc. in the S&P 500?
    • Is Jupiter Neurosciences, Inc. in the NASDAQ 100?
    • Is Jupiter Neurosciences, Inc. in the Dow Jones?
    • When does Jupiter Neurosciences, Inc. report earnings?

    What is the ticker symbol for Jupiter Neurosciences, Inc.?

    The ticker symbol for Jupiter Neurosciences, Inc. is NASDAQ:JUNS

    Does Jupiter Neurosciences, Inc. pay dividends?

    No, Jupiter Neurosciences, Inc. does not pay dividends

    What sector is Jupiter Neurosciences, Inc. in?

    Jupiter Neurosciences, Inc. is in the Healthcare sector

    What industry is Jupiter Neurosciences, Inc. in?

    Jupiter Neurosciences, Inc. is in the Biotechnology industry

    What country is Jupiter Neurosciences, Inc. based in?

    Jupiter Neurosciences, Inc. is headquartered in United States

    When did Jupiter Neurosciences, Inc. go public?

    Jupiter Neurosciences, Inc.'s initial public offering (IPO) was on January 18, 2022

    Is Jupiter Neurosciences, Inc. in the S&P 500?

    No, Jupiter Neurosciences, Inc. is not included in the S&P 500 index

    Is Jupiter Neurosciences, Inc. in the NASDAQ 100?

    No, Jupiter Neurosciences, Inc. is not included in the NASDAQ 100 index

    Is Jupiter Neurosciences, Inc. in the Dow Jones?

    No, Jupiter Neurosciences, Inc. is not included in the Dow Jones index

    When does Jupiter Neurosciences, Inc. report earnings?

    The date for Jupiter Neurosciences, Inc.'s next earnings report has not been announced yet
    On this page